Robert J. Decker
Known title: Controller, CAOCIK: 0001798703
Associated companies
Transaction History
| JNJ | ▲ Buy | Option Exercise | 4,075 | $471K | 2/27/2026 | View on chart |
| JNJ | ▼ Sell | Open Market | 4,075 | $1.0M | 2/27/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 339 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 94 | $23K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 344 | $0 | 2/15/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 95 | $23K | 2/15/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 312 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 104 | $25K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 2,741 | $0 | 2/13/2026 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 762 | $186K | 2/13/2026 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 6,999 | $713K | 2/25/2025 | View on chart |
| JNJ | ▼ Sell | Open Market | 6,999 | $1.2M | 2/25/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 94 | $15K | 2/18/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 339 | $0 | 2/15/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 104 | $16K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 850 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 254 | $40K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,351 | $0 | 2/14/2025 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 372 | $58K | 2/14/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 312 | $0 | 2/13/2025 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 5,635 | $564K | 8/30/2024 | View on chart |
| JNJ | ▼ Sell | Open Market | 5,635 | $930K | 8/30/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 313 | $0 | 2/13/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 86 | $14K | 2/13/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 1,637 | $0 | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 275 | $0 | 2/12/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 523 | $82K | 2/12/2024 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 655 | $0 | 2/8/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 215 | $34K | 2/8/2024 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 397 | $64K | 2/13/2023 | View on chart |
| JNJ | ▲ Buy | Grant | 1,451 | $0 | 2/13/2023 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 581 | $0 | 2/10/2023 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 191 | $31K | 2/10/2023 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 16,928 | $1.5M | 11/18/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 16,928 | $3.0M | 11/18/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 8,462 | $1.5M | 5/26/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 8,462 | $614K | 5/26/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 250 | $44K | 3/15/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 5,000 | $363K | 3/15/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 2,000 | $351K | 3/15/2022 | View on chart |
| JNJ | ▼ Sell | Open Market | 2,750 | $483K | 3/15/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 903 | $0 | 2/15/2022 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 248 | $41K | 2/15/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 866 | $0 | 2/14/2022 | View on chart |
| JNJ | ▼ Sell | Tax Withholding | 263 | $44K | 2/14/2022 | View on chart |
| JNJ | ▲ Buy | Option Exercise | 5,000 | $363K | 12/7/2021 | View on chart |
| JNJ | ▼ Sell | Open Market | 5,000 | $816K | 12/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Johnson & Johnson: Key Takeaways for Long-Term Investors
Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.
Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.